 Does price deregulation increase drug price in China? An interrupted time series analysisYao Xiong, Judy Xu and Yuexia Gao International Journal of Health Planning and Management, 2021, vol. 36, issue 5, 1653-1665 Abstract: Background The Chinese government removed the price ceiling of most drugs in June 2015 to establish a market‐driven pricing system. The purpose of this study is to examine the impact of the elimination of drug ceiling price (EDCP) policy on drug prices. Methods Using a national macro‐level dataset, we employed an interrupted time series method to study the abrupt level and gradual trend changes of Chinese and Western medicine consumer price index (CPI) between June 2014 and June 2017. Results The policy exerted level change on Chinese medicine CPI, increasing 0.201% (95% CI 0.026% to 0.376%, p = 0.026). And the trend in Chinese medicine CPI was still decreased nonsignificantly after the EDCP policy. However, there was no significant price change in Western medicine. Conclusion The EDCP policy has different effects on the prices of Chinese and Western medicines. Therefore, we need to pay more attention to the drug pricing mechanism in the future. Date: 2021 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:bla:ijhplm:v:36:y:2021:i:5:p:1653-1665 Ordering information: This journal article can be ordered from Access Statistics for this article International Journal of Health Planning and Management is currently edited by Calum Paton More articles in International Journal of Health Planning and Management from Wiley Blackwell |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.